Introduction
============

Prolonged intubation time in patients undergoing cardiac surgery can be associated with increased mortality and morbidity.[@b1-tcrm-14-2203]--[@b3-tcrm-14-2203] Studies have shown that patients extubated earlier after the operation have shorter ICU and hospital length of stay (LOS).[@b4-tcrm-14-2203],[@b5-tcrm-14-2203] The guidelines of the Society of Thoracic Surgeons (STS) indicate a 6-hour time point as a definition of "early extubation" and intubation longer than 24 hours as "prolonged intubation".[@b6-tcrm-14-2203] The advocated early extubation time, ie, within 6 hours after the procedure as compared to conventional extubation practices, has been associated with a reduced rate of infections, renal failure, stroke and mortality.[@b7-tcrm-14-2203]--[@b9-tcrm-14-2203] However, the time between 6 and 24 hours has not been adequately studied. Dichotomization of patients into two sub-groups divided by a single time point may miss some of the important information regarding the intermediate time intervals. Advances in surgical and anesthetic techniques bring an on-going interest in early extubation in order to reduce the negative outcomes associated with delayed extubation, as well as any additional costs.[@b10-tcrm-14-2203]

Despite the advocated early 6-hour extubation time, many patients do not fulfill criteria for extubation at this time. One of the reasons is the cardiopulmonary bypass (CPB), responsible for inducing a generalized inflammatory response (complement and neutrophil activation, pro-inflammatory mediator release) that may result in the post-CPB syndrome characterized by an increase in alveolar--arterial oxygen partial pressure gradients (AaDO~2~), decreased lung compliance and increased extravascular lung water.[@b11-tcrm-14-2203],[@b12-tcrm-14-2203] Premature extubation can have serious adverse physiological consequences, including atelectasis, respiratory distress, hypercarbia and hypoxemia.[@b13-tcrm-14-2203]

Studies have reported numerous interventions and peri-operative protocols aimed at meeting the 6-hour time point that were implemented in the cardiac ICUs as an effort to reduce the intubation time.[@b14-tcrm-14-2203],[@b15-tcrm-14-2203] The heterogeneity of patient populations undergoing cardiac surgery may have limited the success of previously suggested protocols and risk prediction models.[@b16-tcrm-14-2203]--[@b19-tcrm-14-2203] The inflection point at which the complications rate rises has not been adequately determined. To verify the validity of previously identified predictors in a homogenous group of relatively low-risk patients, we performed this study with an aim to determine the influence of intubation duration on postoperative morbidity and mortality in patients undergoing isolated coronary artery bypass grafting (CABG) under general anesthesia.

Methods
=======

Study design and patient selection
----------------------------------

We performed a retrospective analysis of data from a prospectively collected institutional database including all operations performed at the Department of Cardiac Surgery of a tertiary university hospital with entries between January 1, 2014 and December 31, 2016. We included all patients undergoing isolated CABG, excluding any patients undergoing a valvular procedure performed in addition to CABG and all CABG without the use of cardio-pulmonary bypass (off-pump CABG \[OPCAB\]). Among 3,065 records in the database that included all cardiac surgery patients, we extracted data on 1,904 patients undergoing isolated CABG. Data on concomitant diseases and demographic information (age, gender, body mass index \[BMI\], history of smoking and admission type) were extracted from the medical documentation. The following co-morbidities were recorded: heart failure according to New York Heart Association (NYHA) and ejection fraction, arterial hypertension, myocardial infarction, atrial fibrillation, extracardiac arteriopathy, internal carotid artery stenosis, COPD, renal failure, stroke and transient ischemic attack. Perioperative risk was calculated using the EuroScore Logistics 2 scale. Laboratory results were part of routine peri-operative blood sampling. Induction of general anesthesia was performed intravenously with fentanyl and etomidate, and a muscle relaxant (pancuronium) to allow tracheal intubation. Maintenance of general anesthesia was inhalational, using sevoflurane with additional doses of fentanyl and a muscle relaxant. After the surgery patients were transferred to a postoperative cardiac ICU, still intubated and mechanically ventilated, sedated to achieve adequate sedation depth (Richmond Agitation Sedation Scale \[RASS\] between −1 and +1) with adequate pain control, using intravenous morphine infusion and a non-opioid analgesic. The initial mode for mechanical ventilation was synchronized intermittent mechanical ventilation with continuous positive airway pressure when the patient regained their respiratory drive and the weaning process was initiated. Patients were extubated when they met pre-defined criteria: normal body temperature, Glasgow Coma Scale 14--15 points, no focal neurological deficit, pain under control, drainage \<100 mL/h, hemodynamic stability (noradrenaline or adrenaline \<0.05 µg/kg/min), absence of significant arrhythmias, PaO~2~ \>60 mmHg, PaCO~2~ \<45 mmHg, SpO~2~ \>95% with FiO~2~ \<0.45, no respiratory distress and normal respiratory rate. Patients were extubated to passive oxygen therapy (facial mask with O~2~ at 5--7 L/min). An arterial blood gas was obtained 30 minutes after extubation to ensure patient safety.

Ethical concerns
----------------

The study was performed in accordance with the Declaration of Helsinki due to its retrospective character a waiver was granted from the Bioethical Committee of the Pomeranian Medical University in Szczecin, Poland, decision no KB-0012/254/06/18. The data entered into the prospectively collected database required written informed consent for surgery, anesthesia and data collection at the time of hospital admission from each patient, as part of routine preoperative assessment, therefore patient consent to review their medical documentation was waived by the Bioethical Committee. To ensure patient data safety only de-identified data was used for analysis.

Intubation time cohorts
-----------------------

The intubation time (in hours, rounded to tenths) was calculated for each patient as a difference between the time when patient left the operating room to be transferred to the cardiac ICU and the time of extubation after the surgery and. We used five pre-defined time intervals of postoperative intubation: 0--6, 6--9, 9--12, 12--24 and over 24 hours. The time stratification approach indicated a threshold of 12-hours at which the risk of 30-day mortality increased, for which a complications risk analysis was performed.

Primary and secondary outcomes
------------------------------

The primary outcome was death within 30 days after the operation, regardless of the cause and ICU LOS (days) and hospital LOS (days). Secondary outcomes included postoperative complications -- neurological (stroke, transient ischemic attack, delirium, seizures), respiratory (pneumonia, respiratory failure), renal (acute kidney injury, hemofiltration), cardiovascular (heart failure, cardiogenic shock, atrial fibrillation), and infectious (sepsis).

Statistical analyses
--------------------

We performed descriptive analysis using the Student's *t*-test for continuous variables, presented as means with SD according to distribution. The chi-squared test was used for categorical variables, which were presented as proportions. A mortality-matched analysis was performed for pre-defined time points (0--6, 6--9, 9--12, 12--24, and \>24 hours), which showed a statistically significant mortality increase in patients intubated for longer than 12 hours and the whole cohort was further sub-divided into ≤12 hours and \>12 hours. The *P*-value of \<0.05 was regarded as statistically significant. Univariate logistic regression analysis was used for subgroups ≤12 hours and \>12 hours for each variable and presented as ORs with 95% CI. Risk factors that were significant in univariate analysis and presented with narrow CI and a *P*-value of \<0.05 were manually entered for multivariate logistic regression analysis. All statistical analyses was performed using licensed software Statistica 12 (StatSoft, Inc., Tulsa, OK, USA), license no JPZP602C295824AR-V.

Results
=======

Results for all time cohorts
----------------------------

The average intubation time after CABG was 14.93±8.63 hours. The intubation percentages in each time cohort were ([Figure 1](#f1-tcrm-14-2203){ref-type="fig"}): 0--6 hours -- 7.8% (148/1,904), 6--9 hours -- 17.3% (329/1,904), 9--12 hours -- 26.8% (511/1,904), 12--24 hours -- 44.4% (846/1,904) and \>24 hours -- 3.7% (70/1,904). The majority of the patients were extubated within 12 hours -- 52.5%. All data on patients with a stratification according to pre-defined time points are shown in [Table 1](#t1-tcrm-14-2203){ref-type="table"}. Age increase was seen across all five cohorts (*P*\<0.001). Patients extubated earlier had higher BMI (*P*=0.032) were mostly men (*P*\<0.001), more often smokers (*P*=0.003), with a lower operative risk (based on EuroScore logistic 2, *P*\<0.001). The admission type did not differ between study cohorts. When accounting for concomitant diseases, patients extubated earlier had less heart failure (NYHA III and IV, *P*\<0.001), less low ejection fraction \<30% (*P*=0.023), less internal carotid artery stenosis (*P*=0.048), less chronic renal failure (*P*\<0.001) and extracardiac arteriopathy (*P*=0.002) than patients with longer intubation times.

Both primary and secondary outcomes data showed significant differences across all time cohorts ([Table 2](#t2-tcrm-14-2203){ref-type="table"}), with lower mortality (*P*\<0.001) and shorter ICU (*P*\<0.001) and hospital stay (*P*\<0.001) for patients extubated earlier.

The differences in mortality across all five time cohorts for post-CABG intubation ([Table 3](#t3-tcrm-14-2203){ref-type="table"}) showed that the OR for mortality increases in patients intubated for longer than 12 hours (OR 2.831, 95% CI 1.216--6.594, *P*=0.016) and further increases if intubation time exceeded 24 hours (OR 8.514, 95% CI 3.283--22.079, *P*\<0.001).

Results for patients with intubation times ≤12 and \>12 hours
-------------------------------------------------------------

Patients extubated within 12 hours after intubation (52.4%, 998/1,904) were younger, mostly males (83.4% vs 72.4%, *P*\<0.001), more often active smokers with lower preoperative risk as shown in [Table 4](#t4-tcrm-14-2203){ref-type="table"}. There were no differences regarding the BMI or the admission type between the two subgroups. When analyzing the comorbid conditions, only heart failure (NYHA III/IV) internal carotid artery stenosis and acute renal failure was more frequent in patients extubated \>12 hours; preoperative hemoglobin was lower and serum creatinine was higher in these patients. The length of CPB and aortic cross-clamping time did not differ between ≤12-hour and \>12-hour intubation times. The rate of reoperation (*P*\<0.001) and intraoperative hemofiltration (*P*\<0.001) was significantly higher in patients extubated after 12 hours. Patients intubated for longer than 12 hours had higher creatinine level at day 1 and required transfusion of more packed red blood cells, although the volume of postoperative drainage did not differ significantly between the two groups.

Patients intubated for longer than 12 hours had higher 30-day mortality (2.02% vs 4.59%, *P*=0.002), longer hospital LOS (9.65 vs 7.68 days, *P*\<0.001) and longer ICU LOS (3.30 vs 2.39 days, *P*\<0.001), but more patients had stroke (*P*\<0.001), postoperative delirium (*P*\<0.001), cardiogenic shock (*P*=0.003), pneumonia (*P*\<0.001) and respiratory failure (*P*\<0.001), acute kidney failure (*P*\<0.001) and hemofiltration (*P*\<0.001), as depicted in [Table 5](#t5-tcrm-14-2203){ref-type="table"}.

Univariate and multivariate analyses
------------------------------------

Univariate analysis showed multiple factors to be associated with intubation exceeding 12 hours ([Table 6](#t6-tcrm-14-2203){ref-type="table"}), yet the multivariate analysis showed that intubation exceeding 12 hours after CABG did not increase the risk of 30-day mortality or length of ICU or hospital stay, but was associated only with increases in the occurrence of postoperative delirium (OR 1.580, 95% CI 1.188--2.102, *P*=0.003) and postoperative hemofiltration due to acute kidney injury (OR 1.302, 95% CI 1.023--1.657, *P*=0.032).

Discussion
==========

The length of intubation and mechanical ventilation after cardiac surgery is a balance between the necessity to extubate the patient early to allow spontaneous breathing and regaining of respiratory independence and the risk of extubating too early and causing atelectasis and secondary respiratory failure and re-intubation.

The results of our pragmatic analysis indicate that the risk of postoperative complications does not increase until the intubation time exceeds 12 hours. The majority of the patients were extubated within 12 hours (52.5%) and only 3.7% remained intubated after 24 hours. Shorter intubation time was seen in younger patients, men, with higher BMI and more often in smokers. The multivariate analysis showed that intubation exceeding 12 hours after CABG does not increase the risk of 30-day mortality or length of ICU or hospital stay, but increases the occurrence of postoperative delirium and postoperative hemofiltration due to acute kidney injury.

Not surprisingly, shorter intubation time is seen in younger patients. Many studies reported that age is a significant predictor of delayed extubation with older patients having longer intubation times.[@b20-tcrm-14-2203]--[@b23-tcrm-14-2203] In a study by Shahbazi and Kazerooni, age was the only predictive factor for delayed extubation.[@b23-tcrm-14-2203] Suematsu et al has shown that age above 70 years was a predictor for delayed extubation time.[@b22-tcrm-14-2203] In a study by Cislaghi et al, age above 65 years was associated with prolonged mechanical ventilation in patients undergoing cardiac surgery.[@b20-tcrm-14-2203],[@b21-tcrm-14-2203]

Shorter intubation times in patients who are overweight or obese comply with the obesity paradox, with increasing BMI being a protective factor associated with improved outcome after cardiac surgery.[@b24-tcrm-14-2203]--[@b26-tcrm-14-2203] According to Stamou et al, the hospital outcome and survival were better for overweight patients undergoing cardiac surgery when compared with patients with normal BMI.[@b24-tcrm-14-2203] A cohort study and meta-analysis performed by Mariscalco et al showed that obesity was associated with lower risks for cardiac surgery patients, excluding reverse causation.[@b25-tcrm-14-2203]

This is the first study to show that intubation time is shorter in patients who are active smokers. Intuitively, smoking should be associated with worse postoperative outcome, being a risk factor for complications after cardiac surgery. It has been reported that cessation of smoking over 1 month prior to cardiac surgery may gradually improve ciliary function and macrophage phagocytic function, decrease the amount of sputum, resulting in the reduction of postoperative pulmonary complications in a few weeks.[@b27-tcrm-14-2203],[@b28-tcrm-14-2203] The relationship between smoking and extubation time in cardiac surgery was reported by Ji et al.[@b29-tcrm-14-2203] Persistent smokers had a higher incidence of pulmonary complications following CABG when compared with non-smokers. Smoking cessation more than 1 month before surgery was expected to reduce early major morbidities following CABG surgery.[@b29-tcrm-14-2203] Contrary to our findings, the smoking group in the study by Ji et al had a significantly higher incidence of postoperative pulmonary complications (7.1% vs 4.5%, *P*=0.0010) and significantly longer duration of mechanical ventilation (9.8±2.6 hour vs 9.4±2.4 hour, *P*\<0.0001) when compared with the nonsmoking group.[@b29-tcrm-14-2203]

Association with sex was also seen in many previous studies, indicating that men perform better after cardiac surgery.[@b20-tcrm-14-2203] Studies have shown that female sex may be a non-modifiable risk factor for prolonged intubation after cardiac surgery.[@b30-tcrm-14-2203]

The rate of postoperative complications increases with the length of intubation time. According to Heringlake et al, postoperative intubation time prolongation was associated with AKI in cardiac surgical patients.[@b31-tcrm-14-2203] Our results indicated that intubation exceeding 12 hours may be associated with AKI requiring hemofiltration (usually due to decreased diuresis and/or fluid overload). Oliver et al hypothesized that perioperative hemofiltration and steroids may attenuate the inflammatory response during CPB, but only hemofiltration reduced time to tracheal extubation for adults after CABG.[@b32-tcrm-14-2203]

This is the first study to show directly that the intubation time over 12 hours increases the risk of postoperative delirium, a well-recognized complication of cardiac surgery.[@b33-tcrm-14-2203] Previous studies have shown that delirium was associated with prolonged ventilation time after cardiac surgery, but used a \>24 hours intubation time-frame.[@b34-tcrm-14-2203]--[@b36-tcrm-14-2203] Jannati et al reported that the ventilator time was associated with delirium during the first 24 hours after cardiac surgery.[@b34-tcrm-14-2203] Kazmierski et al identified prolonged intubation as a risk factor for delirium, yet again this involved intubation \>24 hours.[@b35-tcrm-14-2203] Kobayashi et al indicated that intubation duration of 88.3±212.5 hours vs 37.2±92 hours (*P*=0.0296) was associated with delirium after CABG in patients aged over 75 years.[@b36-tcrm-14-2203]

Studies performed in the 1990s have shown that intubation exceeding 24 hours (prolonged intubation) is associated with increased mortality and morbidity after cardiac surgery.[@b1-tcrm-14-2203],[@b37-tcrm-14-2203],[@b38-tcrm-14-2203] On the other side of the spectrum lies the shorter, 6-hour intubation time, associated with reduced risk of adverse postoperative events and decreased treatment cost.[@b1-tcrm-14-2203],[@b39-tcrm-14-2203] The intermediate period between 6 and 24 hours has not been adequately studied and it is still unclear, what is the ideal time above which the patient deteriorates and their outcome worsens. The 6-hour STS target seems arbitrary. Current guidelines of intubation times should be revisited allowing for more liberal length of postoperative intubation, less aggressive ventilation weaning and extubation after CABG. According to Camp et al, a 9-hour threshold was advocated.[@b39-tcrm-14-2203] Crawford et al have shown that insignificant differences were observed in those extubated in 6--9 hours vs 0--6 hours nor in 9--12 hours vs 0--9 hours; an identical trend was observed for secondary outcomes of PLOS and reintubation.[@b14-tcrm-14-2203] According to Crawford et al, a 12-hour benchmark for maximum duration of intubation may be advisable as the new target in the vulnerable population.[@b14-tcrm-14-2203]

The major limitation of this study is its retrospective character, although data were collected prospectively and not all data were available in the dataset. The multitude of factors that contribute to the duration of intubation after cardiac surgery makes this analysis difficult and prone to bias. The definite strength of our study is a very large number of patients included and the pragmatic evaluation of risk factors for intubation time points in patients undergoing one of the most common surgical interventions worldwide.

Conclusion
==========

The results of this real-life analysis of intubation practices after CABG indicate that earlier extubation occurs in younger patients, males, and surprisingly in smokers. Intubation exceeding 12 hours does not increase the risk of 30-day mortality or hospital and ICU LOS, but is associated with the risk of postoperative delirium and AKI requiring hemofiltration. This study is another voice in the discussion about the new extubation metric that should guide both cardiac anesthetists and surgeons to stratify the risk of prolonged intubation after cardiac surgery and to allocate the resources.
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###### 

Study group characteristics and perioperative data for each intubation time cohort

  Data                                                Intubation time                                                                   
  --------------------------------------------------- ----------------- --------------- --------------- --------------- --------------- ---------
  Demographic data                                                                                                                      
   Age \[years\] (mean ± SD)                          61.98±8.49        63.08±7.55      66.00±7.88      68.07±8.01      70.36±8.31      \<0.001
   BMI \[kg/m^2^\] (mean ± SD)                        29.99±4.58        29.05±4.15      28.94±4.42      28.74±4.32      28.46±4.40      0.032
   Gender, male, n (%)                                132 (89.19)       291 (88.45)     401 (78.47)     618 (73.05)     44 (64.29)      \<0.001
   Smoking, n (%)                                     27 (18.24)        67 (20.43)      91 (17.88)      111 (13.18)     15 (21.74)      \<0.001
  BMI, n (%)                                                                                                                            
   Normal                                             17 (11.49)        51 (15.50)      88 (17.22)      160 (18.91)     18 (25.71)      NS
   Overweight                                         62 (41.89)        147 (44.68)     230 (45.01)     367 (43.38)     28 (40.00)      
   Obese                                              69 (46.62)        131 (39.82)     193 (37.77)     319 (37.71)     24 (34.29)      
  Admission type, n (%)                                                                                                                 
   Elective                                           100 (67.57)       225 (68.39)     354 (69.41)     579 (68.44)     46 (65.71)      NS
   Accelerated                                        37 (25.00)        84 (25.53)      123 (24.12)     208 (24.59)     18 (25.71)      
   Emergency                                          11 (7.43)         20 (6.08)       33 (6.47)       59 (6.97)       6 (8.57)        
  Concomitant diseases                                                                                                                  
   Ejection fraction \<30%, n (%)                     7 (4.73)          21 (6.38)       32 (6.26)       49 (5.79)       11 (15.71)      0.023
   NYHA III and IV, n (%)                             13 (9.85)         24 (8.33)       48 (10.55)      93 (12.30)      17 (27.42)      \<0.001
   Diabetes mellitus, n (%)                           71 (47.97)        144 (43.77)     236 (46.18)     404 (47.75)     29 (41.43)      NS
   Glucose intolerance, n (%)                         8 (5.41)          10 (3.04)       15 (2.94)       32 (3.78)       3 (4.29)        NS
   Transient ischemic attack, n (%)                   2 (1.35)          2 (0.61)        5 (0.98)        12 (1.42)       1 (1.43)        NS
   Stroke, n (%)                                      6 (4.05)          21 (6.38)       34 (6.65)       45 (5.32)       7 (10.00)       NS
   Arterial hypertension, n (%)                       110 (74.32)       241 (73.25)     379 (74.17)     650 (76.83)     54 (77.14)      NS
   Myocardial infarction, n (%)                       80 (54.05)        170 (51.6)      256 (50.1)      462 (54.61)     47 (67.14)      NS
   PTCA/Stenting, n (%)                               48 (32.43)        124 (37.69)     168 (32.88)     267 (31.56)     20 (28.57)      NS
   Atrial fibrillation paroxysmal, n (%)              10 (6.76)         18 (5.47)       29 (5.86)       57 (6.74)       6 (8.57)        NS
   Atrial fibrillation persistent, n (%)              8 (5.41)          11 (3.34)       16 (3.13)       27 (3.19)       2 (2.86)        NS
   Internal carotid artery stenosis, n (%)            7 (4.73)          20 (6.08)       33 (6.46)       73 (8.63)       10 (14.29)      0.048
   COPD, n (%)                                        7 (4.73)          18 (5.47)       28 (5.48)       49 (5.79)       7 (10.00)       NS
   Chronic renal failure, n (%)                       5 (3.38)          16 (4.86)       31 (6.07)       45 (5.32)       12 (17.14)      \<0.001
   Acute renal failure, n (%)                         0 (0.00)          0 (0.00)        0 (0.00)        0 (0.00)        6 (0.71)        NS
   Extracardiac arteriopathy, n (%)                   16 (10.81)        43 (13.07)      101 (19.77)     159 (18.79)     20 (28.57)      0.002
  Operative risk                                                                                                                        
   EuroScore Logistic 2 \[%\] (mean ± SD)             1.87±1.99         1.96±1.97       2.15±2.45       2.42±3.08       5.10±8.80       \<0.001
  Preoperative factors                                                                                                                  
   Ejection fraction \[%\] (mean ± SD)                46.57±9.67        46.63±10.41     47.07±9.82      47.14±9.95      43.51±11.33     NS
   CKMB \[U/L\] (mean ± SD)                           27.95±35.65       23.77±17.72     25.15±24.18     34.03±94.88     82.66±142.61    \<0.001
   Hemoglobin \[mmol/L\] (mean ± SD)                  8.62±0.99         8.69±0.92       8.48±0.92       8.43±0.94       8.12±1.16       \<0.001
   Creatinine \[mg/dL\] (mean ± SD)                   1.00±0.74         0.99±0.64       0.97±0.47       1.04±0.79       1.21±0.53       \<0.001
   GFR \[mL/min/1.73 m^2^\] (mean ± SD)               85.68±19.97       84.26±18.39     81.88±30.79     77.71±31.41     63.83±22.22     \<0.001
  Intraoperative factors                                                                                                                
   CPB time \[min\] (mean ± SD)                       53.16±17.29       48.87±13.35     50.37±13.68     50.02±15.94     60.40±37.05     NS
   Aortic cross-clamping time \[min\] (mean ± SD)     31.85±10.52       30.10±10.09     30.45±9.07      29.66±8.78      30.78±15.80     NS
   Re-operation, n (%)                                5 (3.38)          5 (1.52)        9 (1.76)        45 (5.32)       14 (20)         \<0.001
   Intraoperative hemofiltration, n (%)               28 (18.92)        40 (12.16)      92 (18.00)      178 (21.04)     34 (48.57)      \<0.001
  Postoperative factors                                                                                                                 
   CKMB day 1 \[U/L\] (mean ± SD)                     61.01±67.44       54.59±55.28     55.87±58.40     72.57±148.09    188.12±301.22   \<0.001
   Drainage day 1 \[mL\] (mean ± SD)                  473.82±306.40     461.96±277.51   443.66±317.96   485.93±435.79   697.57±767.97   0.002
   Creatinine (highest) day 1 \[mg/dL\] (mean ± SD)   1.15±0.77         1.21±1.13       1.24±0.79       1.38±1.03       1.88±0.83       \<0.001
   Hemoglobin day 1 \[mmol/L\] (mean ± SD)            6.79±0.77         6.81±0.80       6.66±0.83       6.58±0.85       6.13±0.91       \<0.001
   GFR (lowest) \[mL/min/1.73 m^2^\] (mean ± SD)      78.31±25.29       76.02±23.54     69.64±24.75     63.04±25.03     41.63±21.52     \<0.001
   PRBC transfusion \[units\] (mean ± SD)             2.63±1.74         2.70±2.20       2.62±1.42       3.11±2.22       4.62±3.04       \<0.001

**Note:** The statistical analysis showed *p*\>0.05, therefore this is statistically not significant (NS).

**Abbreviations:** BMI, body mass index; CK, creatinine kinase MB fraction; CPB, cardio-pulmonary bypass; FFP, fresh frozen plasma; GFR, glomerular filtration rate; n, number of patients; NS, not significant; NYHA, New York Heart Association; PRBC, packed red blood cells; PTCA, percutaneous coronary angioplasty.

###### 

Primary and secondary outcomes data for each intubation time cohort

  Postoperative outcomes                    Intubation time                                                          
  ----------------------------------------- ----------------- ------------ ------------- ------------- ------------- ---------
  Primary outcome data                                                                                               
   Mortality -- 30 days, n (%)              7 (4.73)          5 (1.52)     8 (1.57)      31 (3.66)     11 (15.71)    \<0.001
   Hospital LOS (mean ± SD)                 7.05±2.82         7.77±5.35    7.80±4.25     9.13±11.73    15.89±19.63   \<0.001
   ICU LOS (mean ± SD)                      2.23±0.76         2.49±2.77    2.38±1.63     2.96±5.10     7.37±12.31    \<0.001
  Secondary outcome data -- complications                                                                            
   Stroke, n (%)                            2 (1.35)          4 (1.22)     4 (0.78)      19 (2.25)     11 (15.71)    \<0.001
   TIA, n (%)                               1 (0.68)          3 (0.91)     4 (0.78)      10 (1.18)     0 (0)         NS
   Delirium, n (%)                          15 (10.14)        25 (7.6)     56 (10.96)    140 (16.55)   15 (21.43)    \<0.001
   Seizures, n (%)                          1 (0.68)          0 (0.00)     0 (0.00)      3 (0.35)      4 (5.71)      \<0.001
   Cardiogenic shock, n (%)                 3 (2.03)          2 (0.61)     5 (0.98)      16 (1.89)     12 (17.14)    \<0.001
   Pneumonia, n (%)                         1 (0.68)          7 (2.13)     10 (1.96)     35 (4.14)     18 (25.71)    \<0.001
   Respiratory failure, n (%)               6 (4.05)          12 (3.65)    16 (3.13)     48 (5.67)     34 (48.57)    \<0.001
   AKI, n (%)                               7 (4.73)          4 (1.22)     17 (3.33)     46 (5.44)     18 (25.71)    \<0.001
   AKI requiring hemofiltration, n (%)      7 (4.73)          14 (4.26)    15 (2.94)     64 (7.57)     26 (37.14)    \<0.001
   Atrial fibrillation, n (%)               32 (21.62)        55 (16.72)   110 (21.53)   186 (21.99)   15 (21.43)    NS
   Sepsis, n (%)                            1 (0.68)          0 (0.00)     1 (0.20)      1 (0.12)      2 (2.68)      \<0.001

**Abbreviations:** AKI, acute kidney injury; ICU, intensive care unit; LOS, length of stay; n, number of patients; *P*, statistical significance; TIA, transient ischaemic attack.

###### 

Differences in 30-day mortality for different intubation time-points

  Mortality at 30 days           OR      95% CI          *P*-value
  ------------------------------ ------- --------------- -----------
  Intubation time 0--6 hours     0.661   0.271--1.614    NS
  Intubation time 6--9 hours     0.916   0.341--2.460    NS
  Intubation time 9--12 hours    1.513   0.620--3.692    NS
  Intubation time 12--24 hours   2.831   1.216--6.594    0.016
  Intubation time \>24 hours     8.514   3.283--22.079   0.000

**Abbreviations:** NS, not significant; *P*, statistical significance.

###### 

Baseline characteristics and perioperative data for patients intubated for ≤12 hours and \>12 hours during and after CABG

  Data                                                     Intubation time                   
  -------------------------------------------------------- ----------------- --------------- ---------
  Demographic data                                                                           
   Age \[years\] (mean ± SD)                               64.43±8.04        68.25±8.05      \<0.001
   BMI \[kg/m^2^\] (mean ± SD)                             29.14±4.37        28.72±4.32      NS
   Gender, male, n (%)                                     824 (83.40)       663 (72.38)     \<0.001
   Smoking, n (%)                                          185 (18.78)       126 (13.83)     \<0.001
  BMI, n (%)                                                                                 
   Normal                                                  156 (15.79)       180 (19.48)     NS
   Overweight                                              439 (44.43)       397 (42.97)     
   Obesity                                                 393 (39.78)       347 (37.55)     
  Admission type, n (%)                                                                      
   Elective                                                679 (68.79)       632 (68.40)     NS
   Accelerated                                             244 (24.72)       235 (25.43)     
   Emergency                                               64 (6.48)         65 (7.09)       
  Concomitant diseases                                                                       
   Ejection fraction \<30%, n (%)                          60 (6.07)         60 (6.55)       NS
   NYHA III and IV, n (%)                                  85 (9.71)         110 (13.45)     0.016
   Diabetes mellitus, n (%)                                451 (45.65)       433 (47.27)     NS
   Glucose intolerance, n (%)                              33 (3.34)         35 (3.82)       NS
   Transient ischemic attack, n (%)                        9 (0.91)          13 (1.42)       NS
   Stroke, n (%)                                           61 (6.17)         52 (5.68)       NS
   Arterial hypertension, n (%)                            730 (73.89)       704 (76.86)     NS
   Myocardial infarction, n (%)                            506 (51.21)       509 (55.57)     NS
   PTCA/Stenting, n (%)                                    340 (34.41)       287 (31.33)     NS
   Atrial fibrillation paroxysmal, n (%)                   57 (5.77)         63 (6.88)       NS
   Atrial fibrillation persistent, n (%)                   35 (3.54)         29 (3.17)       NS
   Internal carotid artery stenosis, n (%)                 60 (6.07)         83 (9.06)       0.013
   COPD, n (%)                                             53 (5.36)         56 (6.11)       NS
   Chronic renal failure, n (%)                            52 (5.26)         57 (6.22)       NS
   Acute renal failure, n (%)                              0 (0.0)           6 (0.66)        0.032
   Extracardiac arteriopathy, n (%)                        160 (16.19)       179 (19.54)     NS
  Operative risk                                                                             
   EuroScore Logistic 2 \[%\] (mean ± SD)                  2.05±2.23         2.63±3.88       \<0.001
  Preoperative factors                                                                       
   Ejection fraction \[%\] (mean ± SD)                     46.85±9.9         46.86±10.11     NS
   CKMB \[U/L\] (mean ± SD)                                25.10±24.38       37.76±100.09    NS
   Hemoglobin \[mmol/L\] (mean ± SD)                       8.57±0.93         8.40±0.96       \<0.001
   Creatinine \[mg/dL\] (mean ± SD)                        0.98±0.58         1.06±0.77       0.004
   GFR \[mL/min/1.73 m^2^\] (mean ± SD)                    83.24±25.76       76.65±31.01     \<0.001
  Intraoperative factors                                                                     
   CPB time \[min\] (mean ± SD)                            50.29±14.23       50.81±18.60     NS
   Aortic cross-clamping time \[min\] (mean ± SD)          30.54±9.65        29.74±9.48      NS
   Reoperation, n (%)                                      19 (1.92)         59 (6.44)       \<0.001
   Intraoperative hemofiltration, n (%)                    160 (16.19)       212 (23.14)     \<0.001
  Postoperative factors                                                                      
   CKMB day 1 \[U/L\] (mean ± SD)                          56.19±58.75       81.20±167.04    NS
   Drainage day 1 \[mL\] (mean ± SD)                       454.27±303.23     502.10±472.26   NS
   Creatinine \[highest\] day 1 \[mg/dL\] (mean ± SD)      1.22±0.91         1.42±1.02       \<0.001
   Hemoglobin day 1 \[mmol/L\] (mean ± SD)                 42.63±10.18       43.45±12.38     NS
   GFR \[lowest\] day 1 \[mL/min/1.73 m^2^\] (mean ± SD)   73.06±24.67       61.46±25.40     \<0.001
   PRBC transfusion, units (mean ± SD)                     2.65±1.72         3.29±2.38       \<0.001

**Abbreviations:** BMI, body mass index; CK, creatinine kinase MB fraction; CPB, cardio-pulmonary bypass; FFP, fresh frozen plasma; GFR, glomerular filtration rate; n, number of patients; NS, not significant; NYHA, New York Heart Association; PTCA, percutaneous coronary angioplasty; PRBC, packed red blood cells.

###### 

Postoperative complications and mortality for patients intubated ≤12 and \>12 hours

  Postoperative outcomes                 Intubation time                 
  -------------------------------------- ----------------- ------------- ---------
  Primary outcome                                                        
   Mortality at 30 days, n (%)           20 (2.02)         42 (4.59)     0.002
   Hospital LOS, days (mean ± SD)        7.68±4.49         9.65±12.63    \<0.001
   ICU LOS, days (mean ± SD)             2.39±2.00         3.30±6.07     \<0.001
  Secondary outcome                                                      
   Stroke, n (%)                         10 (1.01)         30 (3.28)     \<0.001
   TIA, n (%)                            8 (0.81)          10 (1.09)     0.69
   Delirium, n (%)                       96 (9.72)         155 (16.92)   \<0.001
   Seizures, n (%)                       1 (1.01)          7 (0.76)      0.06
   Cardiogenic shock, n (%)              10 (1.01)         28 (3.06)     0.003
   Pneumonia, n (%)                      18 (1.82)         53 (5.79)     \<0.001
   Respiratory failure, n (%)            34 (3.44)         82 (8.95)     \<0.001
   AKI, n (%)                            28 (2.83)         64 (6.99)     \<0.001
   AKI requiring hemofiltration, n (%)   36 (3.64)         90 (9.83)     \<0.001
   Atrial fibrillation, n (%)            197 (19.94)       201 (21.94)   NS
   Sepsis, n (%)                         2 (0.20)          3 (0.33)      NS

**Abbreviations:** AKI, acute kidney injury; ICU, intensive care unit; LOS, length of stay; n, number of patients; NS, not significant; *P*, statistical significance; TIA, transient ischaemic attack.

###### 

Univariate and multivariate analysis for intubation longer than 12 hours after CABG

                                         Univariate analysis    Multivariate analysis                          
  -------------------------------------- ---------------------- ----------------------- ---------------------- -------
  Primary outcomes                                                                                             
   Mortality 30 days, n (%)              2.326 (1.355--3.992)   0.002                   1.248 (0.628--2.480)   NS
   Hospital LOS (mean ± SD)              1.044 (1.024--1.063)   \<0.001                 1.017 (0.996--1.034)   NS
   ICU LOS (mean ± SD)                   1.075 (1.034--1.119)   \<0.001                 1.030 (0.991--1.071)   NS
  Secondary outcomes                                                                                           
   Stroke, n (%)                         3.312 (1.610--6.813)   0.001                   1.416 (0.642--3.125)   NS
   Delirium, n (%)                       1.893 (1.441--2.485)   \<0.001                 1.548 (1.161--2.064)   0.003
   Cardiogenic shock, n (%)              3.084 (1.489--6.385)   0.002                   1.813 (0.800--4.107)   NS
   Pneumonia, n (%)                      3.310 (1.924--5.693)   \<0.001                 1.584 (0.844--2.974)   NS
   Respiratory failure, n (%)            2.759 (1.830--4.159)   \<0.001                 1.159 (0.683--1.968)   NS
   Acute Kidney Injury (AKI), n (%)      2.575 (1.636--4.054)   \<0.001                 1.158 (0.643--2.085)   NS
   AKI requiring hemofiltration, n (%)   1.558 (1.240--1.959)   \<0.001                 1.302 (1.023--1.657)   0.032
   Heart failure, n (%)                  2.881 (1.936--4.288)   \<0.001                 1.349 (0.779--2.337    NS

**Abbreviations:** CABG, coronary artery bypass grafting; n, number of patients; ICU, intensive care unit; LOS, length of stay; *P*, statistical significance.
